Suneva Medical Introduces Regenica® Recovery Gel
- Innovative aesthetics company unveils new addition to the Regenica® skin care line at the American Academy of Dermatology (AAD) 73rd Annual Meeting in San Francisco
- Regenica® is the only skin care system with Multipotent Resignaling Complex (MRCx™) next generation growth factor technology
- Growing injection-based cosmetic treatment segment to benefit from Regenica® Recovery Gel's healing agents
SAN DIEGO, March 23, 2015 /PRNewswire/ -- Suneva Medical, Inc., a privately-held aesthetics company, today announced the introduction and availability of Regenica® Recovery Gel, a new addition to the Regenica® skin care system. Regenica® Recovery Gel is a soothing balm that is specially formulated to help quickly heal damaged skin. It infuses Multipotent Resignaling Complex (MRCx™) next generation growth factor technology with well-recognized and trusted natural anti-inflammatory and calming agents—arnica, vitamin K, aloe vera, beta-glucan and SymCalmin®—to help in the overall appearance of compromised skin.
"The growing popularity of aesthetic treatments calls for advanced skin care products that support a rapid and healthy healing process," said Nicholas L. Teti, Jr., Chairman and Chief Executive Officer at Suneva Medical. "Regenica® Recovery Gel is uniquely developed for use after common injectable treatments to help patients return more quickly to daily activities and minimize signs of bruising or swelling."
According to the American Academy of Dermatology (AAD), a number of new dermal fillers have been introduced in recent years to replace lost volume in the skin and to shape and sculpt areas that show signs of aging.1 The two most popular cosmetic treatments performed by American Society for Dermatologic Surgery (ASDS) members in 2013 and 2012 were soft-tissue fillers and wrinkle-relaxing injections, both of which enhance the face.2 Addressing injection-based cosmetic treatment growth, Regenica® Recovery Gel was developed to support rapid healing of injection sites. In a recent clinical study, 100% of patients who used Regenica® Recovery Gel daily for one week after having cosmetic injections showed no signs of bruising as early as day three (the first follow-up visit).3
"Regenica® Recovery Gel has delivered remarkable results for my patients and created a better treatment experience," said Dr. Ava Shamban, MD, board-certified dermatologist and key investigator in the clinical research for Regenica® Recovery Gel. "Proven effective, 100% of subjects in a clinical study said they would recommend Regenica® Recovery Gel to a friend and use the product after their next filler injection.3"
Regenica® Recovery Gel is part of the popular Regenica® product line that includes Regenica® Renew SPF 15, Regenica® Replenishing Crème and Regenica® Repair Complex. To learn more about Regenica®, visit www.regenica.com or follow on Facebook: www.facebook.com/regenicaskincare, Twitter: @RegenicaSkin and Instagram: RegenicaSkincare.
For more information on Suneva Medical, visit www.sunevamedical.com.
Regenica® and MRCx™ are trademarks of Suneva Medical, Inc.
About Suneva Medical, Inc.
Suneva Medical, Inc. is a privately-held aesthetics company focused on developing, manufacturing and commercializing novel, differentiated products for the general dermatology and aesthetic markets. The innovative aesthetics leader markets Bellafill®, the only dermal filler on the market that is approved by the U.S. Food and Drug Administration for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years. In markets outside the U.S., Bellafill® is only approved for the correction of nasolabial folds. The company markets Bellafill® in the U.S. and Canada; ArteFill® in South Korea and Singapore; Regenica® skin care in the U.S. and Canada; and ReFissa® tretinoin cream in the U.S. ArteFill® was rebranded to Bellafill® in the U.S. to reflect the transformational outcomes this unique product can provide to patients seeking correction of their acne scars and nasolabial folds. For more information, visit www.sunevamedical.com.
1American Academy of Dermatology, https://www.aad.org/media-resources/stats-and-facts/cosmetic-treatments/cosmetic-dermatology
2American Society for Dermatologic Surgery, 2013, https://www.asds.net/_Media.aspx?id=8032
3 Data on file
Photo: http://photos.prnewswire.com/prnh/20150323/183652
SOURCE Suneva Medical, Inc.
Share this article